(35) found a reduced risk of anti-TB drug-induced hepatitis in active smokers compared to non-smokers, potentially due to nicotine-activating cholinergic anti-inflammatory pathways and reducing liver damage through heme oxygenase-1 induction (35). This evidence concerns the gene HMOX1 and hepatitis A virus infection.